MEI Pharma Inc. Stock
Pros and Cons of MEI Pharma Inc. in the next few years
Pros
?
B****
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
Cons
?
S********** s********
?
M***** P*******
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of MEI Pharma Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| MEI Pharma Inc. | - | - | - | - | - | - | - |
| Heron Therapeutics Inc. | 0.550% | -2.839% | -4.643% | -56.256% | -12.433% | -55.252% | -93.348% |
| Evolus Inc | 0.000% | 25.263% | 27.273% | -63.101% | -12.661% | -44.000% | -47.519% |
| Sangamo Therapeutics Inc. | -0.890% | -15.121% | 6.662% | -60.044% | -7.090% | -87.809% | -96.593% |
Comments
MEI Pharma (NASDAQ:MEIP) was downgraded by analysts at Wall Street Zen from a "hold" rating to a "sell" rating.
Show more
Ratings data for MEIP provided by MarketBeat
MEI Pharma, Inc. (NASDAQ: MEIP) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.
Show more
Ratings data for MEIP provided by MarketBeat
MEI Pharma, Inc. (NASDAQ: MEIP) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.
Show more
Ratings data for MEIP provided by MarketBeat